Kotaro Hama Selected Research

Kotaro Hama Research Topics

Disease

8	Neoplasms (Cancer) 01/2023 - 07/2002
4	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 08/2021 - 12/2013
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 10/2004
3	Melanoma (Melanoma, Malignant) 07/2010 - 06/2006
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2004
2	Fibrosis (Cirrhosis) 01/2020 - 10/2010
2	Stomach Neoplasms (Stomach Cancer) 01/2006 - 12/2004
1	Necrosis 01/2023
1	COVID-19 10/2021
1	Infections 10/2021
1	Virus Diseases (Viral Diseases) 10/2021
1	Inborn Genetic Diseases (Disease, Hereditary) 08/2021
1	Atherosclerosis 01/2018
1	Zellweger Syndrome (Zellweger's Syndrome) 12/2013
1	Neuralgia (Stump Neuralgia) 10/2010
1	Pathologic Processes 10/2010
1	Colonic Neoplasms (Colon Cancer) 10/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2010
1	Chronic Hepatitis C 07/2007
1	Glioblastoma (Glioblastoma Multiforme) 06/2006
1	Ovarian Neoplasms (Ovarian Cancer) 10/2004
1	Carcinoma (Carcinomatosis) 01/2004
1	Ductal Carcinoma 01/2004

Drug/Important Bio-Agent (IBA)

10	lysophosphatidic acidIBA 01/2020 - 07/2002
5	LipidsIBA 01/2023 - 08/2010
5	EnzymesIBA 01/2022 - 06/2006
5	Lysophosphatidic Acid ReceptorsIBA 01/2020 - 01/2004
4	Fatty Acids (Saturated Fatty Acids)IBA 08/2021 - 12/2013
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2018 - 04/2004
3	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 07/2007 - 04/2004
2	SphingolipidsIBA 01/2023 - 10/2021
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 07/2010 - 06/2006
2	Messenger RNA (mRNA)IBA 10/2004 - 01/2004
2	Proteins (Proteins, Gene)FDA Link 10/2004 - 01/2004
2	alkylglycerophosphoethanolamine phosphodiesteraseIBA 04/2004 - 07/2002
1	dihydroceramide desaturaseIBA 01/2023
1	CeramidesIBA 01/2023
1	Alkaline CeramidaseIBA 01/2023
1	CeramidasesIBA 01/2023
1	Cathepsin GIBA 01/2022
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2022
1	Platelet Activating FactorIBA 01/2022
1	Serine Proteases (Serine Protease)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 10/2021
1	safingol (sphinganine)IBA 10/2021
1	retinamideIBA 10/2021
1	dihydroceramideIBA 10/2021
1	FenretinideIBA 10/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 08/2021
1	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 08/2021
1	GlycosphingolipidsIBA 08/2021
1	Adenosine Triphosphate (ATP)IBA 08/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	Acyl Coenzyme A (Acyl CoA)IBA 01/2020
1	Cholesterol Esters (Cholesteryl Esters)IBA 01/2018
1	Glycerol (Glycerine)FDA LinkGeneric 10/2010
1	Phosphates (Orthophosphate)IBA 10/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2010
1	Lipoproteins (Lipoprotein)IBA 08/2010
1	nucleotide pyrophosphataseIBA 07/2010
1	Conditioned Culture MediaIBA 07/2010
1	Choline (Choline Chloride)IBA 07/2007
1	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 07/2007
1	Proto-Oncogene Proteins c-metIBA 01/2006
1	ErbB Receptors (EGF Receptor)IBA 01/2006
1	Monoclonal AntibodiesIBA 10/2004
1	3- (4- (4- ((1- (2- chlorophenyl)ethoxy)carbonyl amino)-3-methyl-5-isoxazolyl) benzylsulfanyl) propanoic acidIBA 04/2004
1	Actins (F Actin)IBA 01/2004

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2002